How This Company Profits From Fighting World Hunger

Shares of Monsanto  (NYSE: MON  )  have underperformed in the past three months, after the company announced it will drop all of its European Union requests for the approval of new genetically modified crops. Meanwhile, the government keeps investigating Monsanto's business, looking for antitrust violations. But considering Monsanto is the global leader in the increasingly important agricultural biotechnology industry (more than 170 million hectares of land are already planted with genetically modified crops), is this a buying opportunity? 

MON Chart

Source: YCharts

A great story behind the stock
For the past 10 years, Monsanto managed to grow its revenue base moderately. This could change if Monsanto manages to get its GM crops approved by most world legislatures. Considering how controversial GM crops remain in the minds of most citizens and politicians, is this possible? Well, maybe not in the short run, but the long run shows several hopeful trends for the company.

According to a recent study, if the world is to grow enough food for the projected global population in 2050 -- 9.6 billion people -- agricultural productivity would need to rise by at least 60%. Currently, productivity of corn, rice, wheat, and soybean crops is increasing 0.9% to 1.6% every year.

This is just too low to meet the requirements for 2050. At this rate, these crops would increase 38% to 67% by 2050, rather than the required 60% to 110%.

Source: Monsanto Investor Relations, presentation slides.

Furthermore, in some countries (such as in Eastern Europe), crop yields are actually decreasing. At the same time, the cost of food keeps rising globally. And looking at the global market for corn, Monsanto argues that demand growth has by far outpaced supply.

Who can solve this problem?
Monsanto's yield-improving technologies and GM seeds may be the answer. It owns a massive germplasm bank across six continents, and would be more than happy to sell GM seeds to most farmers in the world, if that becomes legally possible. It already has a strong presence in the Americas, with more than 150 million hybrid planted acres so far. According to Morningstar, roughly 90% of the soybeans and 80% of the corn grown in the U.S. contain a Monsanto trait . 

If the remaining world regions follow the pattern shown in America, Monsanto's cash flow could see a massive increase in volume. And the urgent need for yield improvement could force negative consumer sentiment toward GM crops to change.

Naturally, Monsanto is not the only company trying to capture market share in this promising market. A wider global acceptance of GM crops would also benefit Monsanto's main competitors Syngenta  (NYSE: SYT  )  and DuPont  (NYSE: DD  ) . 

Syngenta is strong in crop protection products and corn seeds. Although the latest quarter showed revenue increased only 2%, the company remains ambitious in its long-term horizon, and is planning to practically double its level of sales by 2020: a 10% CAGR for the next seven years.

To achieve its plan, Syngenta will need to steal market share in emerging markets like Latin America, where Monsanto is well positioned. And although Syngenta's seeds are as competitive as Monsanto's DeKalb or DuPont's Pioneer, neither giant will make things easier for the Swiss company. Most likely, every player will see its margins hurt.

Dupont, on the other hand, is betting on Africa. The company just announced the acquisition of a majority stake in Pannar Seed, probably Africa's largest seed producer. This could be a great strategic move, if you consider that about 20% of the global area under maize cultivation is said to be in that continent, where the average yield is roughly a fifth of the equivalent in Europe.

Notice, though, that DuPont's soybean business depends on Monsanto, because it borrows Monsanto's technology in exchange for $802 million. In the future, Monsanto can increase the price of royalties to obtain better margins. This risk can't be ignored.

Clean balance sheet, high dividend and active repurchases
Monsanto has $2.1 billion in long-term debt. This is huge, but well below the $3.1 billion of cash and equivalents that Monsanto has accumulated so far. Plus, a low 0.16 debt-to-equity ratio shows only a very small part of Monsanto's growth is financed by debt, unlike Syngenta's 0.435. Although the company has enough cash, I expect most of the current debt to be used in financing a recently approved $2 billion share repurchase program, which will commence at the end of the current $1 billion program. This program will complement the quarterly dividend of $0.375 per share (roughly 1.5% annual yield).

Notice that debt is not a worry here considering that last year Monsanto generated more than $3 billion in cash flow from operating activities.

Final Foolish thoughts
My overall rating is positive. Monsanto's fundamentals remain strong after the latest quarter. Plus, this stock has a great catalyst. The demand for food will keep increasing, and considering that there just aren't enough resources available to feed everybody with organic food, Monsanto's technology could become a must-use within this decade. 


Read/Post Comments (3) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On September 12, 2013, at 9:06 PM, funfundvierzig wrote:

    Let's take a Smartphone photo of how investors collectively value these three major agricultural competitors:

    By market cap at tonight's close, Sept. 12, 2013:

    Syngenta $36.3 billion.

    Monsanto $54.9 billion.

    DuPont $53.6 billion.

    It would appear that investors place a higher value, higher by $1.3 billion, on Monsanto than they do the much larger DuPont chemicals and seeds conglomerate. That means smallish Monsanto is worth more than DuPont, chemicals, materials, building supplies, TIO2, Teflon, Kevlar, plastics, seeds, crop protection, nutrition, biofuels and corn-made carpets and clothes combined!


  • Report this Comment On September 13, 2013, at 2:12 PM, dwil1949 wrote:

    Monsonto is selling poison. Their production is dropping each year per acre. their crops require more and more intensive costly spraying. It is costing the farmers more and more to get less and less.

  • Report this Comment On September 14, 2013, at 6:33 AM, ValentineDyall wrote:

    What rubbish. All agricultural food activity profits from fighting world hunger at home or abroad.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2633555, ~/Articles/ArticleHandler.aspx, 10/1/2016 1:21:42 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 4 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 4:01 PM
MON $102.20 Up +0.41 +0.40%
Monsanto CAPS Rating: ***
DD $66.97 Up +0.60 +0.90%
DuPont CAPS Rating: ****
SYT $87.60 Down -0.13 -0.15%
Syngenta CAPS Rating: *****